We are live on
!
Find out more
CRC
Curi RMB Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
18.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+323.6%
AUM
$2.81B
AUM Growth
+$127M
(+4.7%)
Cap. Flow
-$91.8M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
504
New
39
Increased
117
Reduced
218
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$21.3M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.7M |
| 3 |
Salesforce
CRM
|
+$14M |
| 4 |
iShares MBS ETF
MBB
|
+$11.5M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$35M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$14.6M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$14.5M |
| 4 |
TJX Companies
TJX
|
+$8.92M |
| 5 |
Apple
AAPL
|
+$6.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.09% |
| 2 | Technology | 16.43% |
| 3 | Healthcare | 12.41% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Citigroup
C
$226B
| $333K | 0.01% |
7,369
-1,000
| -12% | -$45.4K |
|
402
Constellium
CSTM
$3.99B
| $333K | 0.01% |
28,150
-53
| -0.2% | -$619 |
|
403
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $332K | 0.01% |
+7,099
| New | +$323K |
|
404
Caribou Biosciences
CRBU
$164M
| $331K | 0.01% |
52,768
-22,019
| -29% | -$196K |
|
405
Vanguard Ultra-Short Bond ETF
VUSB
$8.92B
| $322K | 0.01% |
6,574
| – | – |
|
406
Intel
INTC
$513B
| $322K | 0.01% |
12,181
-631
| -5% | -$17.5K |
|
407
Emerson Electric
EMR
$88.3B
| $318K | 0.01% |
3,315
-280
| -8% | -$25.2K |
|
408
Verra Mobility
VRRM
$744M
| $314K | 0.01% |
22,739
-4,206
| -16% | -$63.9K |
|
|
DMF
409
DELISTED
BNY Mellon Municipal Income
DMF
| $313K | 0.01% |
+50,000
| New | +$309K |
|
410
Occidental Petroleum
OXY
$55.9B
| $306K | 0.01% |
4,859
+744
| +18% | +$50.7K |
|
411
AT&T
T
$163B
| $303K | 0.01% |
16,449
-1,959
| -11% | -$35.1K |
|
412
Zoetis
ZTS
$30.5B
| $301K | 0.01% |
2,053
-551
| -21% | -$81.5K |
|
413
3M
MMM
$94.3B
| $299K | 0.01% |
2,986
-991
| -25% | -$101K |
|
414
Schwab Fundamental US Small Company Index ETF
FNDA
$9.38B
| $299K | 0.01% |
12,818
| – | – |
|
415
Royal Bank of Canada
RY
$293B
| $296K | 0.01% |
3,151
| – | – |
|
|
ANSS
416
DELISTED
Ansys
ANSS
| $294K | 0.01% |
1,217
| – | – |
|
417
General Motors
GM
$76.8B
| $292K | 0.01% |
8,692
-105
| -1% | -$3.88K |
|
418
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $290K | 0.01% |
39,875
-48,576
| -55% | -$352K |
|
|
XIFR
419
XPLR Infrastructure LP
XIFR
$1.08B
| $290K | 0.01% |
4,140
+254
| +7% | +$19K |
|
420
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $289K | 0.01% |
8,960
| – | – |
|
421
Belden
BDC
$5.19B
| $288K | 0.01% |
4,000
| – | – |
|
422
Vertex Pharmaceuticals
VRTX
$126B
| $287K | 0.01% |
+995
| New | +$303K |
|
423
Hershey
HSY
$36.6B
| $283K | 0.01% |
+1,224
| New | +$282K |
|
424
Ingersoll Rand
IR
$33.7B
| $280K | 0.01% |
5,365
-729
| -12% | -$37.2K |
|
425
Nike
NKE
$61.9B
| $278K | 0.01% |
2,372
-459
| -16% | -$46.2K |
|
Similar funds
AC
RMDI
F
EW
DSC
O
ACM
AS
Curi RMB Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Curi RMB Capital held 504 positions worth $2.81B, up 4.7% from $2.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Curi RMB Capital withdrew a net $91.8M in Q4 2022, closing 41 positions and reducing 218 holdings. Its most notable exit was Edwards Lifesciences, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Curi RMB Capital opened a new position in iShares MBS ETF worth $11.6M.
- Curi RMB Capital's largest Q4 2022 buy was iShares MBS ETF: 125,026 shares worth $11.6M.
- Curi RMB Capital added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $21.3M increase.
- Curi RMB Capital's biggest Q4 2022 reduction was TJX Companies, cutting an estimated $8.92M.
- Curi RMB Capital fully exited Edwards Lifesciences in Q4 2022, selling an estimated $35M.
- Curi RMB Capital's ten largest holdings make up 17% of its $2.81B portfolio in Q4 2022.
- Curi RMB Capital opened 39 new positions and closed 41 in Q4 2022.
- Curi RMB Capital's portfolio value rose 4.7% quarter-over-quarter to $2.81B.
Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.